• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉输液系统的污染——更换输液器的影响。

Contamination of intravenous infusion systems--the effect of changing administration sets.

作者信息

Jakobsen C J, Grabe N, Nielsen E, Højbjerg T, Damm M, Lorentzen K, Ersgaard H V, Villadsen J, Heebøl-Holm B, Madsen J I

出版信息

J Hosp Infect. 1986 Nov;8(3):217-23. doi: 10.1016/0195-6701(86)90116-7.

DOI:10.1016/0195-6701(86)90116-7
PMID:2878025
Abstract

Intravenous administration sets were changed at varying time intervals between every 24 h and 120 h in 387 patients. The rates of intraluminal contamination of the cannulae and of local inflammation were measured in relation to the time interval between changing sets. There was no correlation between phlebitis and intraluminal contamination, but a significant association was found between phlebitis and fever, infusion of potassium at greater than 10 mmol l-1, Venflon type 140 and infusion of blood or intralipid. No correlation was found between septicaemia and intraluminal contamination of the infusion systems. Contamination of cannulae increased slightly with time, but this was not statistically significant. We conclude that there will be no clinical benefit by daily changing of administration sets, compared with changing up to every fifth day.

摘要

387例患者静脉给药装置的更换时间间隔在每24小时至120小时之间不等。根据更换装置的时间间隔,测定了套管腔内污染率和局部炎症发生率。静脉炎与管腔内污染之间无相关性,但发现静脉炎与发热、输注钾浓度大于10 mmol/L、140型静脉留置针、输注血液或脂肪乳之间存在显著关联。败血症与输液系统管腔内污染之间无相关性。套管污染随时间略有增加,但无统计学意义。我们得出结论,与每五天更换一次相比,每天更换给药装置并无临床益处。

相似文献

1
Contamination of intravenous infusion systems--the effect of changing administration sets.静脉输液系统的污染——更换输液器的影响。
J Hosp Infect. 1986 Nov;8(3):217-23. doi: 10.1016/0195-6701(86)90116-7.
2
Contamination of intravenous infusion fluid: effects of changing administration sets.静脉输液液体污染:更换输液器的影响。
Ann Intern Med. 1979 May;90(5):764-8. doi: 10.7326/0003-4819-90-5-764.
3
A randomized trial of 72- versus 24-hour intravenous tubing set changes in newborns receiving lipid therapy.接受脂质治疗的新生儿静脉输液管72小时更换与24小时更换的随机试验。
Infect Control Hosp Epidemiol. 1999 Jul;20(7):487-93. doi: 10.1086/501657.
4
Effect of 24-hour intravenous tubing set change on the sterility of repackaged fat emulsion in neonates.24小时更换静脉输液管对新生儿重新包装脂肪乳剂无菌性的影响。
Ann Pharmacother. 2004 Oct;38(10):1603-7. doi: 10.1345/aph.1E141. Epub 2004 Aug 24.
5
A prospective clinical comparison of two intravenous polyurethane cannulae.两种静脉用聚氨酯套管的前瞻性临床比较。
Anaesth Intensive Care. 1996 Dec;24(6):705-9. doi: 10.1177/0310057X9602400614.
6
Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective.
JAMA. 1987 Oct 2;258(13):1777-81.
7
Studies on the microbiological safety of the valved side-port of the 'Venflon' cannula.“Venflon”套管带阀侧口的微生物安全性研究。
J Hosp Infect. 1985 Jun;6(2):201-8.
8
Optimal timing for intravenous administration set replacement.静脉输液器更换的最佳时机。
Cochrane Database Syst Rev. 2005 Oct 19(4):CD003588. doi: 10.1002/14651858.CD003588.pub2.
9
A prospective randomized study to evaluate safety and efficacy of heparin topical solution (1000 IU/ml) compared to heparin topical gel (200 IU/g) in prevention of infusion-associated phlebitis.一项前瞻性随机研究,旨在评估肝素外用溶液(1000 IU/ml)与肝素外用凝胶(200 IU/g)在预防输液相关静脉炎方面的安全性和有效性。
Indian J Pharmacol. 2018 Nov-Dec;50(6):344-349. doi: 10.4103/ijp.IJP_201_17.
10
Comparison of phlebitis rates with Buretrol and Harvard Mini-Infuser for administration of i.v. piggyback medications.使用输液管和哈佛微量输液器静脉滴注药物时静脉炎发生率的比较。
NITA. 1986 Nov-Dec;9(6):475-7.

引用本文的文献

1
Intravascular device administration sets: replacement after standard versus prolonged use in hospitalised patients-a study protocol for a randomised controlled trial (The RSVP Trial).血管内装置给药套件:住院患者标准使用与延长使用后的更换——一项随机对照试验的研究方案(RSVP试验)
BMJ Open. 2015 Feb 3;5(2):e007257. doi: 10.1136/bmjopen-2014-007257.
2
Optimal timing for intravascular administration set replacement.血管内给药装置更换的最佳时机。
Cochrane Database Syst Rev. 2013 Sep 15;2013(9):CD003588. doi: 10.1002/14651858.CD003588.pub3.
3
Potential for extending survival of peripheral intravenous infusions.
延长外周静脉输液存活时间的潜力。
BMJ. 1992 Mar 7;304(6827):619-24. doi: 10.1136/bmj.304.6827.619.